Hepatocellular carcinoma (HCC), the third leading cause of cancer-related mortality worldwide, has witnessed a significant increase in incidence over the last two decades in the United States [1]. Predominantly arising in cirrhotic livers, HCC is associated with a dismal average 5-year survival rate of 18 % [2,3].

Read the full article on ejradiology.com